Cholera Vaccines/immunology; Diarrhea/prevention & control; Gastroenteritis/prevention & control; Vibrio cholerae/immunology; Viral Vaccines/immunology; Viruses/immunology; Clinical Trials as Topic; Diarrhea/epidemiology; Diarrhea/microbiology; Diarrhea/virology; Drug Approval; Drug Discovery; Drug Evaluation, Preclinical; Gastroenteritis/epidemiology; Gastroenteritis/microbiology; Gastroenteritis/parasitology; Gastroenteritis/virology; Humans

ALA, aminolevulenic acid; ASC, antibody secreting cell; Ace, accessory cholera enterotoxin; CT, cholera toxin; CT-A cholera toxin A subunit; CT-B cholera toxin B subunit; Cep, core encoded pilus; E. coli; ETEC; ETEC, enterotoxigenic E. coli; GEMS, global enteric multi-center study; HA/P, hemaglutinin protease; HBGA, histo-blood group antibodies; IS, intussusception; IgA, immunoglobulin A; IgG, immunoglobulin G; IgM, immunoglobulin M; LB, lower boundary; LLR, Lanzhou Lamb Rotavirus vaccine; LPS, lipopolysaccharide; MPL, monophosphoril lipid A; MSH, mannose-sensitive hemaglutinin pilus; REST, rotavirus efficacy and safety trial; RITARD; RR, relative risk, CI, confidence interval; RecA, recombinase A; SAES, serious adverse events; SRSV, small round virus, ORF, open reading frame; STEC; STEC, shigatoxin producing E. coli; TCP, toxin co-regulated pilus; V. cholerae; VA1.3, vaccine attempt 1.3; VLP, virus like particle; VLPs, virus like particles, VRPs, virus replicon particles; VP, viral proteins; WHO, World Health Organization; Zot, zonula occludens toxin; acute diarrhea; campylobacter; enteric pathogens; gastroenteritis; norovirus; removable intestinal tie-adult rabbit diarrhea; rotavirus; salmonella; shigella; vaccines